Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)
Close on Nov 17, 2026Market cap $458.11MP/E –Yield –
Assembly Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Assembly Biosciences's profit margin for the twelve months ending Jun 30, 2026 was -0.1%. For fiscal 2025 it was -8.5%, against -140.9% the year before. The highest annual figure on record is -8.5% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8.5% | +132.4 |
| FY2024 | Dec 31, 2024 | -140.9% | +713.9 |
| FY2023 | Dec 31, 2023 | -854.8% | +1221.6 |
| FY2021 | Dec 31, 2021 | -2076.4% | −1997.8 |
| FY2020 | Dec 31, 2020 | -78.6% | +533.1 |
| FY2019 | Dec 31, 2019 | -611.6% | +1.4 |
| FY2018 | Dec 31, 2018 | -613.0% | −138.4 |
| FY2017 | Dec 31, 2017 | -474.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -28.8% | +77.1 |
| Q1 FY2026 | Mar 31, 2026 | -110.5% | −16.9 |
| Q4 FY2025 | Dec 31, 2025 | 52.0% | +192.5 |
| Q3 FY2025 | Sep 30, 2025 | -85.2% | +55.2 |
| Q2 FY2025 | Jun 30, 2025 | -105.9% | +24.8 |
| Q1 FY2025 | Mar 31, 2025 | -93.6% | +63.3 |
| Q4 FY2024 | Dec 31, 2024 | -140.5% | +12.6 |
| Q3 FY2024 | Sep 30, 2024 | -140.4% | +160.2 |
| Q2 FY2024 | Jun 30, 2024 | -130.7% | +3670.5 |
| Q1 FY2024 | Mar 31, 2024 | -156.9% | −147.2 |
| Q4 FY2023 | Dec 31, 2023 | -153.0% | −171.5 |
| Q3 FY2021 | Sep 30, 2021 | -300.7% | +352.5 |
| Q4 FY2020 | Dec 31, 2020 | -3801.2% | −3233.0 |
| Q3 FY2020 | Sep 30, 2020 | -9.7% | +581.1 |
| Q2 FY2020 | Jun 30, 2020 | 18.5% | +619.2 |
| Q1 FY2020 | Mar 31, 2020 | -653.1% | +43.2 |
| Q4 FY2019 | Dec 31, 2019 | -568.2% | +132.3 |
| Q3 FY2019 | Sep 30, 2019 | -590.8% | −88.3 |
| Q2 FY2019 | Jun 30, 2019 | -600.7% | +232.3 |
| Q1 FY2019 | Mar 31, 2019 | -696.3% | −240.5 |
| Q4 FY2018 | Dec 31, 2018 | -700.4% | −609.7 |
| Q3 FY2018 | Sep 30, 2018 | -502.4% | −41.1 |
| Q2 FY2018 | Jun 30, 2018 | -833.0% | −256.5 |
| Q1 FY2018 | Mar 31, 2018 | -455.8% | +1580.9 |
| Q4 FY2017 | Dec 31, 2017 | -90.7% | – |
| Q3 FY2017 | Sep 30, 2017 | -461.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -576.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -2036.7% | – |
See a number that looks wrong?